Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

First six years of implementing colorectal cancer screening in the Osijek-Baranja County, Croatia--can we do better?

Samardzić S, Mihaljević S, Dmitrović B, Milas J, Puntarić D, Tadijan D, Jelić K.

Coll Antropol. 2013 Sep;37(3):913-8.

PMID:
24308237
2.

Ontario's ColonCancerCheck: results from canada's first province-wide colorectal cancer screening program.

Rabeneck L, Tinmouth JM, Paszat LF, Baxter NN, Marrett LD, Ruco A, Lewis N, Gao J.

Cancer Epidemiol Biomarkers Prev. 2014 Mar;23(3):508-15. doi: 10.1158/1055-9965.EPI-13-0956. Epub 2014 Jan 17.

3.

Men with negative results of guaiac-based fecal occult blood test have higher prevalences of colorectal neoplasms than women with positive results.

Brenner H, Hoffmeister M, Birkner B, Stock C.

Int J Cancer. 2014 Jun 15;134(12):2927-34. doi: 10.1002/ijc.28618. Epub 2013 Dec 11.

4.

Results of National Colorectal Cancer Screening Program in Croatia (2007-2011).

Katičić M, Antoljak N, Kujundžić M, Stamenić V, Skoko Poljak D, Kramarić D, Stimac D, Strnad Pešikan M, Samija M, Ebling Z.

World J Gastroenterol. 2012 Aug 28;18(32):4300-7. doi: 10.3748/wjg.v18.i32.4300.

5.

Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.

Dekker N, van Rossum LG, Van Vugt-van Pinxteren M, van Stiphout SH, Hermens RP, van Zelst-Stams WA, van Oijen MG, Laheij RJ, Jansen JB, Hoogerbrugge N.

Eur J Cancer. 2011 Jul;47(10):1571-7. doi: 10.1016/j.ejca.2011.01.022. Epub 2011 Feb 28.

6.

Early detection of colorectal cancer with faecal occult blood test screening.

Paimela H, Malila N, Palva T, Hakulinen T, Vertio H, Järvinen H.

Br J Surg. 2010 Oct;97(10):1567-71. doi: 10.1002/bjs.7150.

PMID:
20603855
7.

Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: a French population-based controlled study (Wintzenheim trial).

Denis B, Gendre I, Aman F, Ribstein F, Maurin P, Perrin P.

Eur J Cancer. 2009 Dec;45(18):3282-90. doi: 10.1016/j.ejca.2009.06.015. Epub 2009 Aug 6.

PMID:
19665368
10.
11.

Short term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test.

Denis B, Ruetsch M, Strentz P, Vogel JY, Guth F, Boyaval JM, Pagnon X, Ebelin JF, Gendre I, Perrin P.

Gut. 2007 Nov;56(11):1579-84. Epub 2007 Jul 6.

12.

Comparison of guaiac and immunological fecal occult blood tests in colorectal cancer screening: the patient perspective.

Deutekom M, van Rossum LG, van Rijn AF, Laheij RJ, Fockens P, Bossuyt PM, Dekker E, Jansen JB.

Scand J Gastroenterol. 2010 Nov;45(11):1345-9. doi: 10.3109/00365521.2010.497937. Epub 2010 Jun 21.

PMID:
20560814
13.

Guaiac versus immunochemical tests: faecal occult blood test screening for colorectal cancer in a rural community.

Hughes K, Leggett B, Del Mar C, Croese J, Fairley S, Masson J, Aitken J, Clavarino A, Janda M, Stanton WR, Tong S, Newman B.

Aust N Z J Public Health. 2005 Aug;29(4):358-64.

PMID:
16222934
14.

Risk for colorectal cancer in elderly persons and possible methodologies for their screening.

Rozen P, Shabtai EI, Liphshitz I, Barchana M.

Eur J Gastroenterol Hepatol. 2011 May;23(5):431-7. doi: 10.1097/MEG.0b013e328345bc38.

PMID:
21448071
15.

Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.

van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, Verbeek AL, Jansen JB, Dekker E.

Gastroenterology. 2008 Jul;135(1):82-90. doi: 10.1053/j.gastro.2008.03.040. Epub 2008 Mar 25.

PMID:
18482589
16.

Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopy.

Sharp L, Tilson L, Whyte S, O'Ceilleachair A, Walsh C, Usher C, Tappenden P, Chilcott J, Staines A, Barry M, Comber H.

Br J Cancer. 2012 Feb 28;106(5):805-16. doi: 10.1038/bjc.2011.580. Epub 2012 Feb 16.

17.

Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008.

Choi KS, Lee HY, Jun JK, Shin A, Park EC.

J Gastroenterol Hepatol. 2012 Jun;27(6):1070-7. doi: 10.1111/j.1440-1746.2011.06944.x.

PMID:
22004224
18.

A sensitive guaiac faecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese population.

Wong BC, Wong WM, Cheung KL, Tong TS, Rozen P, Young GP, Chu KW, Ho J, Law WL, Tung HM, Lai KC, Hu WH, Chan CK, Lam SK.

Aliment Pharmacol Ther. 2003 Nov 1;18(9):941-6.

19.

Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site.

Steele RJ, McClements P, Watling C, Libby G, Weller D, Brewster DH, Black R, Carey FA, Fraser CG.

Gut. 2012 Apr;61(4):576-81. doi: 10.1136/gutjnl-2011-300535. Epub 2011 Sep 19.

PMID:
21930729

Supplemental Content

Support Center